You are here: Industry Insights > Market News > German premier Angela Merkel marks Merck’s 350 years

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

PVP-K30-----pharma excipients(CAS No.9003-39-8)

Tobramycin

Povidone iodine 20% powder

Povidone iodine 10% powder

SULBACTAM SODIUM STERILE

Food Additives Bulk Sucralose Neotame Advantame Powder

German premier Angela Merkel marks Merck’s 350 years

newsnowMay 14, 2018

Tag: German , premier Angela Merkel , Merck’s 350 years

Favorites

German Premier Angela Merkel was among about 900 guests who attended festivities in Darmstadt, Germany, on May 3 marking the 350th anniversary of drug and specialty chemical firm Merck KGaA. Merck timed the opening of a new innovation center at its Darmstadt headquarters with the anniversary. "The fundamental principles on which our company is based have withstood every transformation," Frank Stangenberg-Haverkamp, a member of the Merck family, told guests. The family continues to hold a majority stake in the firm.

Register as Visitor to CPhI China 2018!

Previous:Changing of the guard at European chemical firms

Next:Chinese chemical firms forced to stop production

InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia in China

PharmaSourcesSeptember 19, 2024

InnoCare Pharma announced today the approval of the Investigational New Drug (IND) to conduct the clinical trial of B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in combination with azacitidine for acute myeloid leukemia (AML) in China.

Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner

PharmaSourcesSeptember 18, 2024

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

PharmaSourcesSeptember 14, 2024

German premier Angela Merkel marks Merck’s 350 years | Pharmasources.com

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

Biotech NewswireAugust 28, 2024

Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.

You may like
More>>

Herolab 4L commercial floor-standing large-capacity refrigerated centrifuge HiCen SR, Germany

German Herolab 2L benchtop high-speed centrifuge HiCen T

German Heraeus Gilson liquid deuterium lamp

German Herolab 4L large-capacity benchtop centrifuge HiCen GT

German Herolab 800ml benchtop universal high-speed centrifuge UniCen M

German Heraeus to replace Hitachi liquid deuterium lamp

German Herolab 2L Floor Standing High-Speed Centrifuge HiCen F

German Herolab 120ml benchtop small high-speed centrifuge MicroCen M

bis-carboxyethyl germanium sesquioxide (Ge-132)

German Herolab 120ml benchtop small high-speed refrigerated centrifuge MicroCen MR

German premier Angela Merkel marks Merck’s 350 years﻿

Related News